Related Experiment Videos

Genotoxicity of quercetin in cultured mammalian cells

Mutation Research
|April 1, 1984
PubMed

Insights

Quercetin did not induce mutations in most tests, but it increased SCEs when combined with BrdUrd. Liver homogenate reduced quercetin's clastogenic effects, potentially explaining its negative carcinogenicity results.

Area of Science:

  • Toxicology
  • Genetics
  • Biochemistry

Background:

  • Quercetin is a naturally occurring flavonol with potential health benefits.
  • Its genotoxic and mutagenic potential in mammalian cells requires thorough investigation.

Purpose of the Study:

  • To evaluate quercetin's ability to induce SCEs and gene mutations in mammalian cells.
  • To assess the influence of metabolic activation (liver homogenate) on quercetin's genotoxicity.

Main Methods:

  • Exposure of V79 Chinese hamster cells and mouse lymphoma L5178Y cells to quercetin.
  • Assays for sister chromatid exchanges (SCEs) and HGPRT/TK-deficient mutants.
  • Inclusion of liver homogenate and BrdUrd in specific experimental conditions.

Main Results:

  • Quercetin did not induce HGPRT-deficient mutants in V79 or L5178Y cells.
  • A significant, dose-related increase in SCEs was observed only when quercetin was combined with BrdUrd.
  • A weak increase in TK-deficient mutants in L5178Y cells was noted, but abolished by liver homogenate.

Conclusions:

  • Quercetin exhibits limited genotoxic potential in mammalian cells under standard conditions.
  • Its clastogenic effect is dependent on BrdUrd presence and is mitigated by metabolic activation.
  • These findings may reconcile quercetin's in vitro genotoxicity with negative in vivo carcinogenicity data.

Related Concept Videos